This article delves into the fascinating world of KETOTIFEN, a compound with the CAS number 34580-13-7. It explores the various aspects of KETOTIFEN, including its chemical properties, potential applications, and the knowledge that is essential for understanding its power. The article aims to provide a comprehensive overview of KETOTIFEN, highlighting its significance in different fields and the importance of knowing its properties and uses.
KETOTIFEN, with the chemical abstracts service (CAS) number 34580-13-7, is a compound that has garnered attention for its unique properties and potential applications. This synthetic compound belongs to the class of antihistamines and has been studied for its role in various therapeutic areas. Understanding the power of KETOTIFEN requires an exploration of its chemical structure, pharmacological effects, and potential uses.
KETOTIFEN is a white to off-white crystalline powder that is sparingly soluble in water. Its molecular formula is C18H19Cl2N3O, and it has a molecular weight of 367.25 g/mol. The compound contains a benzene ring, a thiophene ring, and a pyridine ring, which contribute to its pharmacological activity. These structural features make KETOTIFEN a versatile compound with potential applications in various therapeutic areas.
KETOTIFEN exhibits antihistaminic, anti-inflammatory, and bronchodilator properties. It acts as a potent antagonist of histamine H1 receptors, which makes it effective in treating allergic reactions. Additionally, KETOTIFEN has been shown to inhibit the release of inflammatory mediators, such as leukotrienes and prostaglandins, which are involved in the pathogenesis of allergic diseases. These pharmacological effects make KETOTIFEN a promising candidate for the treatment of conditions like asthma and allergic rhinitis.
The potential applications of KETOTIFEN are diverse and span across various therapeutic areas. In the field of respiratory medicine, KETOTIFEN has shown promise in the management of asthma, particularly in children. Its ability to reduce airway inflammation and improve lung function makes it a valuable addition to the treatment arsenal for asthmatic patients. Moreover, KETOTIFEN has been investigated for its potential use in the treatment of allergic rhinitis, urticaria, and other allergic conditions.
The mechanism of action of KETOTIFEN involves its interaction with histamine H1 receptors and other relevant targets. By blocking these receptors, KETOTIFEN prevents the binding of histamine, which is a key mediator of allergic reactions. Additionally, KETOTIFEN has been found to inhibit the release of inflammatory mediators, thereby reducing the severity of allergic symptoms. This dual action makes KETOTIFEN a versatile compound with potential therapeutic benefits.
The development and use of KETOTIFEN are subject to regulatory considerations, including safety assessments and approval processes. Extensive research has been conducted to evaluate the safety profile of KETOTIFEN, and it has been found to have a favorable safety profile with minimal side effects. However, as with any medication, it is essential to consider individual patient factors and follow appropriate dosing guidelines to ensure safe and effective use.
In conclusion, KETOTIFEN, with the CAS number 34580-13-7, is a compound with significant potential in various therapeutic areas. Its unique chemical properties, pharmacological effects, and potential applications make it a subject of interest for researchers and healthcare professionals. Understanding the power of KETOTIFEN requires knowledge of its chemical structure, mechanism of action, and safety profile. As research continues to unfold, KETOTIFEN may play an increasingly important role in the treatment of allergic and respiratory conditions.
KETOTIFEN, CAS 34580-13-7, antihistamine, asthma, allergic rhinitis, pharmacological effects, mechanism of action, safety profile
English (United States) 
English (Australia) 
Spanish 
Portuguese